Korean J Dermatol.  2007 Apr;45(4):378-380.

Cutaneous Plasmacytosis Improved by PUVA Therapy

Affiliations
  • 1Department of Dermatology, Chungnam National University School of Medicine, Daejeon, Korea. jhoon@cnu.ac.kr
  • 2Department of Dermatology, Ajou University School of Medicine1, Suwon, Korea.

Abstract

Cutaneous plasmacytosis is a rare disorder characterized by multiple red-brown plaques, mainly on the trunk, which histologically show a marked hyperplasia of mature plasma cells with no mitotic figures or cellular atypia. It is sometimes accompanied by extracutaneous symptoms like lymphadenopathy or interstitial pneumonia, but without plasma cell infiltration. Although many treatments such as corticosteroid lesional injection, cyclophosphamide, melphalan, systemic PUVA, and local tacrolimus application have been introduced for cutaneous plasmacytosis, there is no reported post-treatment data on cutaneous plasmacytosis in Korea. We report a case of a Korean male patient who was diagnosed with cutaneous plasmacytosis which was improved by PUVA therapy.

Keyword

Cutaneous plasmacytosis

MeSH Terms

Cyclophosphamide
Humans
Hyperplasia
Korea
Lung Diseases, Interstitial
Lymphatic Diseases
Male
Melphalan
Plasma Cells
PUVA Therapy*
Tacrolimus
Cyclophosphamide
Melphalan
Tacrolimus
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr